Report Categories Report Categories

Report Categories

industry Category

All

Total: 2 records, 1 pages

Global Live Attenuated Influenza Vaccine (LAIV) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 08 Jan 2024

date Pharma & Healthcare

new_biaoQian Live Attenuated Influenza Vaccine (LAIV)

According to our (Global Info Research) latest study, the global Live Attenuated Influenza Vaccine (LAIV) market size was valued at USD 7964.6 million in 2023 and is forecast to a readjusted size of USD 12000 million by 2030 with a CAGR of 6.0% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Live Attenuated Influenza Vaccine (LAIV) Supply, Demand and Key Producers, 2023-2029

date 19 Feb 2023

date Pharma & Healthcare

new_biaoQian Live Attenuated Influenza Vaccine (LAIV)

The global Live Attenuated Influenza Vaccine (LAIV) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

Add To Cart

industry 08 Jan 2024

industry Pharma & Healthcare

new_biaoQian Live Attenuated Influenza Vaccine (LAIV)

According to our (Global Info Research) latest study, the global Live Attenuated Influenza Vaccine (LAIV) market size was valued at USD 7964.6 million in 2023 and is forecast to a readjusted size of USD 12000 million by 2030 with a CAGR of 6.0% during review period.

USD3480.00

addToCart

Add To Cart

industry 19 Feb 2023

industry Pharma & Healthcare

new_biaoQian Live Attenuated Influenza Vaccine (LAIV)

The global Live Attenuated Influenza Vaccine (LAIV) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

addToCart

Add To Cart